Analysis of choline alfoscerate effectiveness in chronic ocular ischemic syndrome

Kamilov Kh.М.

Tashkent Institute of Postgraduate Medical Education, Ministry of Health of the Republic of Uzbekistan, 51 Parkent St., Tashkent, Uzbekistan, 100009

Kasimova M.S.

Tashkent Institute of Postgraduate Medical Education, Ministry of Health of the Republic of Uzbekistan, 51 Parkent St., Tashkent, Uzbekistan, 100009

Makhkamova D.К.

Tashkent Institute of Postgraduate Medical Education, Ministry of Health of the Republic of Uzbekistan, 51 Parkent St., Tashkent, Uzbekistan, 100009

Analysis of choline alfoscerate effectiveness in chronic ocular ischemic syndrome

Authors:

Kamilov Kh.М., Kasimova M.S., Makhkamova D.К.

More about the authors

Journal: Russian Annals of Ophthalmology. 2016;132(2): 73‑76

DOI: 10.17116/oftalma2016132273-76

Downloaded: 28

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Kamilov KhМ, Kasimova MS, Makhkamova DК. Analysis of choline alfoscerate effectiveness in chronic ocular ischemic syndrome. Russian Annals of Ophthalmology. 2016;132(2):73‑76. (In Russ.)
https://doi.org/10.17116/oftalma2016132273-76

Подписка 2025 (Russian Annals of Ophthalmology)

Close metadata

Recommended articles:

Laboratory diagnostics of «key» sexually transmitted infections (literature review). Part 1. Russian Journal of Clinical Dermatology and Venereology. 2023;(6):643-650

Laboratory diagnostics of neurosyphilis: ways of optimization. Part 1. «Classical» research methods. Russian Journal of Clinical Dermatology and Venereology. 2023;(6):652-660

Experience of clinical use of fluvoxamine for the treatment of comorbid depression in childhood and adolescence. S.S. Korsakov Journal of Neurology and Psychiatry. 2023;(11-2):14-21

Sexual dysfunction on the background of antidepressant therapy. S.S. Korsakov Journal of Neurology and Psychiatry. 2023;(11-2):115-121

Pseudotumorous form of primary central nervous system vasculitis. S.S. Korsakov Journal of Neurology and Psychiatry. 2023;(12):141-147

Use of Atezolizumab in patients with advanced small cell lung cancer. P.A. Herzen Journal of Oncology. 2023;(6):63-67

The use of Mexidol in patients with mild (moderate) cognitive impairment: results of a meta-analysis. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(1):82-88

Plasma and salivary acetylcholinesterase activity in amyotrophic lateral sclerosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(1):128-134

Diagnostics of HIV-infection in the Chechen Republic: current state and prospects. Russian Journal of Preventive Medicine. 2024;(1):17-24

Reflexology in patient rehabilitation with postoperative pain. (Literature review). Problems of Balneology, Physiotherapy and Exercise Therapy. 2023;(6):103-106

Aim — to investigate the effectiveness of choline alphoscerate in patients with chronic ocular ischemic syndrome (OIS) and coexisting cerebrovascular disease. Material and methods. We performed a comprehensive examination of 51 patients aged 46—72 years (57.8±6.82 years on average) and diagnosed with OIS. Patients were divided into two groups. In group 1 (main group, 26 patients) the standard therapy was supplemented with choline alphoscerate. Group 2 (controls, 25 patients) received the standard therapy only. Results. Clinical and functional examinations revealed a more rapid and stable improvement of visual acuity in the choline alphoscerate group. Conclusion. Development and application of an adequate combination therapy for patients with ocular ischemic syndrome has yielded an increase in visual acuity, visual fields, and the mean light sensitivity of the retina as well as an improvement of ocular hemodynamics.

Keywords:

ocular ischemic syndrome

diagnosis

treatment

choline alfoscerate

neuroprotective therapy

Authors:

Kamilov Kh.М.

Tashkent Institute of Postgraduate Medical Education, Ministry of Health of the Republic of Uzbekistan, 51 Parkent St., Tashkent, Uzbekistan, 100009

Kasimova M.S.

Tashkent Institute of Postgraduate Medical Education, Ministry of Health of the Republic of Uzbekistan, 51 Parkent St., Tashkent, Uzbekistan, 100009

Makhkamova D.К.

Tashkent Institute of Postgraduate Medical Education, Ministry of Health of the Republic of Uzbekistan, 51 Parkent St., Tashkent, Uzbekistan, 100009

List of references:

Kiseleva T, Tarasova L, Fokin A. Glaznoi ishemicheskii sindrom. M.: Meditsina; 2003. (In Russ.)
Makkaeva S. Osobennosti glaznogo ishemicheskogo sindroma pri distsirkulyatornoi entsefalopatii. Dis. d-ra med. nauk. M.; 2010. (In Russ.)
Ponomareva M. Diagnostika i medikamentoznaya korrektsiya narushenii gemodinamiki pri ishemicheskoi neiropatii zritel'nogo nerva u bol'nykh s serdechno-sosudistymi zabolevaniyami. Dis. d-ra med. nauk. M.; 2010. (In Russ.)
Maurice E. Langham. Ischemia and loss of autoregulation in ocular and cerebral diseases. Berlin: Springer; 2009:121-125.
Stulin I. Kholina al'fostserat v lechenii bol'nykh khronicheskoi tserebral'noi ishemiei. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2009;109(7):87-89. (In Russ.)
Vlasov S. Izmeneniya organa zreniya pri patologicheskoi izvitosti i stenoziruyushchem ateroskleroze sonnykh arterii. Vestnik oftal'mologii. 2010;5:58-62. (In Russ.)
Zhaboedov G, Skripnik R. Porazheniya zritel'nogo nerva. Kiev: Meditsina; 2006. (In Ukr.)
Legeza S. Diagnosticheskie vozmozhnosti ul'trazvuka, komp'yuternoi tomografii i yaderno-magnitnogo rezonansa pri patologii zritel'nogo nerva. Oftal'mol. zhurnal. 2009;3:27-28. (In Russ.)
Kiseleva T. Glaznoi ishemicheskii sindrom (klinika, diagnostika, lechenie). Dis. d-ra med. nauk. M.; 2001. (In Russ.)
Kiseleva T, Tarasova L, Fokin A, Bogdanov A. Krovotok v sosudakh glaza pri dvukh tipakh techeniya glaznogo ishemicheskogo sindroma. Vestnik oftal'mologii. 2001;5:22-24. (In Russ.)

Close metadata